UK TimesUK Times
  • Home
  • News
  • TV & Showbiz
  • Money
  • Health
  • Science
  • Sports
  • Travel
  • More
    • Web Stories
    • Trending
    • Press Release
What's Hot

M20 J12 eastbound access | Eastbound | Broken down vehicle

28 January 2026
Manchester United’s Patrick Dorgu to be out for weeks with hamstring injury | Manchester News

Manchester United’s Patrick Dorgu to be out for weeks with hamstring injury | Manchester News

28 January 2026

First minister Eluned Morgan’s ‘car crash interview’ highlights Labour divide | UK News

28 January 2026
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
UK TimesUK Times
Subscribe
  • Home
  • News
  • TV & Showbiz
  • Money
  • Health
  • Science
  • Sports
  • Travel
  • More
    • Web Stories
    • Trending
    • Press Release
UK TimesUK Times
Home » Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity only
Money

Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity only

By uk-times.com16 January 2026No Comments2 Mins Read
Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity only
Share
Facebook Twitter LinkedIn Pinterest Email

It is administered as 3 injections of 2.4 mg for weight management in adult patients with obesity only, in addition to a reduced-calorie diet and exercise, who have a Body Mass Index (BMI) of 30kg/m² or higher.  

This does not apply to overweight patients with a BMI of less than 30kg/m² using Wegovy for weight management or for patients using Wegovy to lower their risk of serious heart problems.  

Patients should always use this medicine exactly as their prescriber tells them and to check with their doctor, pharmacist or nurse if they’re not sure.  

When a patient with obesity first starts using Wegovy, the starting dose is 0.25mg per week. A prescribing healthcare professional will then instruct a patient to gradually increase their dose every 4 weeks until they reach the dose of 2.4 mg per week. 

If needed, a dose increase to 7.2 mg per week (3 injections of 2.4 mg) can be made after a minimum of 4 weeks on 2.4 mg. The maximum dose is 7.2 mg per week.

For the Wegovy 7.2 mg weight management dose, patients will need to inject three doses of 2.4 mg, one after each other on the same day. The injections can be given in the same body area but should be at least 5cm apart. Patients must change the needle between each dose and may need to use multiple pens.  

Each pen contains four 2.4 mg doses. Patients should not discard the pen until their fourth dose has been taken. Partially used pens should be stored in the fridge with the needle removed. Patients should make sure they have a sufficient supply of pens to complete their dose before they start injecting. Once all four 2.4mg doses have been used, patients should dispose of the pen safely, as instructed by their prescriber.  

Anyone who suspects they are having a side effect from this medicine should talk to their doctor, pharmacist or nurse and report it directly to the MHRA Yellow Card scheme, either through the website (https//yellowcard.mhra.gov.uk/) or by searching the Google Play or Apple App stores for MHRA Yellow Card.  

Notes to editors 

For weight management 

Dose escalation Weekly Dose
Week 1–4 0.25mg
Week 5–8 0.5mg
Week 9–12 1mg
Week 13–16 1.7mg
From week 17 2.4mg
From week 21 – for adult patients with obesity, if needed 7.2mg
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

Related News

Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity only

Minister Pollard speech at ADS Annual Dinner 2026

28 January 2026
Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity only

The UK remains committed to supporting implementation of Resolution 2803 and forging a peaceful future for Israelis and Palestinians UK statement at the UN Security Council

28 January 2026
Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity only

Demolition of UNRWA headquarters in East Jerusalem joint statement

28 January 2026
Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity only

Printing firm boss sentenced after fraudulently obtaining second Covid loan

28 January 2026
Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity only

Liz Kendall’s speech at Bloomberg

28 January 2026
UKGI Stewardship Code Report  – UK Government Investments (UKGI)

UKGI Stewardship Code Report  – UK Government Investments (UKGI)

28 January 2026
Top News

M20 J12 eastbound access | Eastbound | Broken down vehicle

28 January 2026
Manchester United’s Patrick Dorgu to be out for weeks with hamstring injury | Manchester News

Manchester United’s Patrick Dorgu to be out for weeks with hamstring injury | Manchester News

28 January 2026

First minister Eluned Morgan’s ‘car crash interview’ highlights Labour divide | UK News

28 January 2026

Subscribe to Updates

Get the latest UK news and updates directly to your inbox.

© 2026 UK Times. All Rights Reserved.
  • Privacy Policy
  • Terms of use
  • Advertise
  • Contact Us

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version